Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X


press

Mission Bio wins CYTO Innovation and QB3@953 Amgen Golden Ticket Awards

Mission Bio recently won two awards in June 2016, including the CYTO Innovation Award at CYTO 2016 in Seattle, Washington, and the QB3@953 Amgen Golden Ticket Award. The CYTO Innovation Award recognizes the best presentation from the CYTO 2016 Technology Showcase, which highlights novel technologies for cell analysis that are in early stages of development to commercialization. The QB3@953 Amgen Golden Ticket Award supports the research and development efforts of startups with one year of lab space at the QB3@953 incubator, along with access to the scientific and business expertise from Amgen. Read more


press
Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market Expansion
press
Mission Bio Announces Launch of First Single-Cell Multiple Myeloma Multiomics Solution Aimed to Transform Translational Research and Therapy Development
press
Mission Bio’s Tapestri Platform Unveils Insights into Targeted Therapy and Residual Disease Assessment for Multiple Myeloma
press
Mission Bio's New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell Products
REQUEST QUOTE